# A Laser Detection for Bladder Cancer by (Photodynamic) Spectra of Urine

> **NCT02101931** · PHASE3 · COMPLETED · sponsor: **Princess Al-Johara Al-Ibrahim Cancer Research Center** · enrollment: 100 (actual)

## Conditions studied

- Transitional Cell Carcinoma of the Bladder

## Interventions

- **DRUG:** Amino levulinic Acid

## Key facts

- **NCT ID:** NCT02101931
- **Lead sponsor:** Princess Al-Johara Al-Ibrahim Cancer Research Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2016-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02101931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02101931, "A Laser Detection for Bladder Cancer by (Photodynamic) Spectra of Urine". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02101931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*